ArticlePharmaceutical research2015
Erratum to: Improved Pharmacokinetic and Biodistribution Properties of the Selective Urokinase Inhibitor PAI-2 (SerpinB2) by Site-Specific PEGylation: Implications for Drug Delivery.
Kara Lea Vine et al.PubMed ↗Publisher ↗
No numbers read from the abstract.